英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

metallurgist    
n. 冶金家,冶金学者

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Tetrabenazine Alternatives Compared - Drugs. com
    Austedo may be used to treat Huntington’s chorea or tardive dyskinesia and works by blocking the action of VMAT2 which is a protein that controls the transfer of chemical messengers between nerves i View more Prescription only Ingrezza may be used to treat adults with tardive dyskinesia or chorea associated with Huntington's disease
  • Indirect Treatment Comparison Between Ingrezza and Austedo to . . .
    Ingrezza (valbenazine; Neurocrine Biosciences, San Diego, CA) may provide more benefit in early treatment of chorea symptoms associated with Huntington disease (HD) than Austedo (deutetrabenazine; Teva Pharmaceuticals, Tel Aviv, Israel), according to results of a study presented at the 2023 International Congress of Parkinson’s Disease and Movement Disorders
  • Austedo: Dosage, side effects, alternatives, and more
    Alternatives for chorea related to Huntington’s disease Austedo and Ingrezza have a boxed warning from the FDA regarding the risk of depression and thoughts of suicide in people with
  • Austedo® vs Ingrezza®: Selecting the Right Medication
    Understanding Austedo and Ingrezza Before diving into the specifics of Austedo and Ingrezza, it is important to understand the conditions they are used to treat Tardive dyskinesia is a movement disorder characterized by repetitive, involuntary movements of the face, tongue, and other body parts It is often caused by long-term use of certain
  • Ingrezza Alternatives Compared - Drugs. com
    More about Austedo (deutetrabenazine) More about Propranolol: Ratings Reviews: Ingrezza has an average rating of 6 1 out of 10 from a total of 19 ratings on Drugs com 53% of reviewers reported a positive effect, while 37% reported a negative effect
  • List of 22 Tardive Dyskinesia Medications Compared - Drugs. com
    Treatments for tardive dyskinesia include deutetrabenazine (Austedo, Austedo XR), valbenzaine , tetrabenazine , amantadine, vitamin B6 (pyridoxine) and pyridoxal-5-phosphate, and vitamin E The routine use of benzodiazepines should be discouraged Other treatments may be used off-label
  • Austedo vs Ingrezza: How do they compare? - Drugs. com
    Austedo, Austedo XR, Ingrezza and Ingrezza Sprinkles are used to treat the movement disorders chorea, which is associated with Huntington’s Disease, and also to treat tardive dyskinesia Austedo, Austedo XR, Ingrezza and Ingrezza Sprinkles are from a group that is called VMAT2 inhibitors (inhibits vesicular monoamine transporter type 2)
  • Austedo vs. Xenazine: Which Medication Is Right for You . . .
    Austedo comes as 6 mg, 9 mg, and 12 mg tablets Austedo XR comes as 6 mg, 12 mg, and 24 mg tablets Austedo dosages are a bit more simple than Xenazine dosages: Austedo: You’ll likely start off by taking one 6 mg tablet twice daily Every week, you have the option to increase your total daily dose by 6 mg until your symptoms are under control
  • Comparative Analysis of Deutetrabenazine and Valbenazine as . . .
    Uhlyar S, Rey JA Valbenazine (Ingrezza): The first FDA-approved treatment for tardive dyskinesia Pharmacy and Therapeutics 2018; 43(6): 328 [PMC free article] [Google Scholar] 17 Park B Austedo XR, a Once-Daily Formulation of Deutetrabenazine, Gets FDA Approval MPR Monthly Prescribing Reference 2023; NA–NA [Google Scholar] 18
  • Finally, Effective Treatments for Tardive Dyskinesia | 2021 . . .
    In 2017, the FDA approved two agents to treat TD, valbenazine (Ingrezza) and deutetrabenazine (Austedo), dramatically improving management options Valbenazine and deutetrabenazine inhibit the vesicular monoamine transporter 2 (VMAT2), depleting serotonin, norepinephrine, and—most important for TD symptom reduction—dopamine
  • Treatments for Tardive Dyskinesia: What Pharmacists Should Know
    Austedo has a black box warning for an increased risk of depression and suicidality with patients with Huntington's disease Product Cost The annual cost for Ingrezza (two 30 count bottles of 40 mg capsules per month) is $151,920 per Lexi-Drugs 7 This price may decrease with the introduction of the 80 mg capsules later this year or early 2018 6
  • FDA Clears Ingrezza Sprinkle for Bipolar-Linked Tardive . . .
    The new granule formulation offers an alternative to Ingrezza’s once-daily capsule valbenazine, which also comes in 40, 60, and 80 milligram dosages, per bpHope’s network site, Everyday Health The only other approved medication for tardive dyskinesia is deutetrabenazine (Austedo), per Everyday Health





中文字典-英文字典  2005-2009